We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.18B
Cap. Flow %
-24.44%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Real Estate 14.75%
2 Consumer Staples 11.78%
3 Consumer Discretionary 6.16%
4 Financials 6.01%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEI
76
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$15.7M 0.33%
56,000
-54,067
-49% -$15.8M
AEE icon
77
Ameren
AEE
$30B
$15.7M 0.33%
450,000
+99,998
+29% +$3.46M
RL icon
78
Ralph Lauren
RL
$23.6B
$15.2M 0.32%
92,538
-70,000
-43% -$12.1M
DUK icon
79
Duke Energy
DUK
$96.6B
$15M 0.31%
225,000
+97,950
+77% +$6.68M
CYT
80
DELISTED
CYTEC INDS INC
CYT
$15M 0.31%
+369,088
New +$14.3M
ES icon
81
Eversource Energy
ES
$27.1B
$15M 0.31%
+363,049
New +$15.4M
PKY
82
DELISTED
Parkway, Inc.
PKY
$14.9M 0.31%
839,999
+137,226
+20% +$2.4M
TYC
83
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$14.8M 0.31%
+403,974
New +$14.6M
HPP
84
Hudson Pacific Properties
HPP
$729M
$14.7M 0.31%
107,780
+3,383
+3% +$492K
CMS icon
85
CMS Energy
CMS
$22.3B
$14.4M 0.3%
547,500
+123,339
+29% +$3.35M
BMR
86
DELISTED
BIOMED REALTY TRUST INC
BMR
$14.3M 0.3%
769,998
+67,225
+10% +$1.32M
SIVB
87
DELISTED
SVB Financial Group
SIVB
$14.2M 0.3%
164,647
+119,140
+262% +$10.3M
AKR icon
88
Acadia Realty Trust
AKR
$2.84B
$14.2M 0.29%
+573,555
New +$14.3M
CCEP icon
89
Coca-Cola Europacific Partners
CCEP
$47.9B
$13.9M 0.29%
345,001
-789,136
-70% -$30M
RAX
90
DELISTED
Rackspace Hosting Inc
RAX
$13.5M 0.28%
+256,469
New +$11.9M
WR
91
DELISTED
Westar Energy Inc
WR
$13.4M 0.28%
436,500
+29,618
+7% +$947K
ROST icon
92
Ross Stores
ROST
$81.6B
$13.3M 0.28%
+365,890
New +$12.5M
SBNY
93
DELISTED
Signature Bank
SBNY
$12.9M 0.27%
140,717
+42,186
+43% +$3.8M
AAT
94
American Assets Trust
AAT
$1.38B
$12.8M 0.27%
420,000
+665
+0.2% +$21K
HHH icon
95
Howard Hughes
HHH
$4.06B
$12.6M 0.26%
117,487
-37,343
-24% -$3.9M
FMER
96
DELISTED
FIRSTMERIT CORP
FMER
$12.6M 0.26%
+578,126
New +$12.6M
PCG icon
97
PG&E
PCG
$37.4B
$12.5M 0.26%
304,981
-158,372
-34% -$6.88M
TOL icon
98
Toll Brothers
TOL
$14.1B
$12.4M 0.26%
383,812
+80,535
+27% +$2.6M
HIW icon
99
Highwoods Properties
HIW
$3.47B
$12.4M 0.26%
350,000
+200,000
+133% +$7.11M
ROIC
100
DELISTED
Retail Opportunity Investments Corp.
ROIC
$12.1M 0.25%
874,999
+286,277
+49% +$3.89M

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.18B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.